Skip to main content

Table 2 Genotype frequencies in Tajiks compared with four other populations

From: Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China

SNP ID

Gene

Category

Allele

Tajik genotype frequencies

pvalues against four populations (after Bonferroni correction)

Family

Phase

A

B

AA(%)

AB(%)

BB(%)

CHB

JPT

CEU

YRI

rs1045642

ABCB1

ABC transporters

others

T

C

34.3

45.5

20.2

8.49E-03

3.42E-02

3.10E-01

2.17E-18

rs1128503

ABCB1

ABC transporters

others

T

C

32.3

51.5

16.2

3.09E-02

8.73E-01

1.69E-02

3.03E-19

rs2032582

ABCB1

ABC transporters

others

G

T

18

49.4

32.6

9.02E-01

6.07E-01

8.24E-02

-

rs975833

ADH1A

alcohol dehydrogenase

phase I

G

C

55.6

37.4

7.1

4.86E-16

3.45E-14

6.46E-01

5.79E-01

rs1229984

ADH1B

alcohol dehydrogenase

phase I

G

A

48

45

7

3.76E-12

7.23E-11

9.18E-11

1.26E-10

rs2066702

ADH1B

alcohol dehydrogenase

phase I

C

T

95

5.1

0

2.97E-01

2.97E-01

1.94E-01

1.61E-11

rs698

ADH1C

alcohol dehydrogenase

phase I

A

G

44.3

45.4

10.3

1.21E-09

3.22E-09

1.24E-02

7.40E-11

rs1801252

ADRB1

adrenergic receptors

others

G

A

3

34.3

62.6

1.22E-05

1.52E-05

-

2.53E-06

rs1801253

ADRB1

adrenergic receptors

others

C

G

63.6

32.3

4

6.12E-01

3.88E-01

5.87E-02

4.12E-04

rs1042713

ADRB2

adrenergic receptors

others

G

A

36

49

15

4.49E-03

5.67E-01

7.34E-01

6.05E-02

rs1042714

ADRB2

adrenergic receptors

others

G

C

14

40

46

1.26E-03

3.39E-05

2.70E-02

9.85E-03

rs2066853

AHR

AHR

others

G

A

69

27

4

1.18E-05

7.65E-08

6.87E-02

9.06E-08

rs4680

COMT

COMT

phase II

A

G

31

45

24

9.95E-05

1.56E-05

5.25E-01

3.15E-05

rs28399454

CYP2A6

cytochrome P450

phase I

G

/

100

0

0

-

-

1.00E + 00

7.81E-07

rs3745274

CYP2B6

cytochrome P450

phase I

G

T

46

36

18

1.07E-03

2.03E-03

5.17E-02

1.50E-01

rs28399499

CYP2B6

cytochrome P450

phase I

T

/

100

0

0

-

-

-

2.04E-06

rs4244285

CYP2C19

cytochrome P450

phase I

G

A

85

15

0

1.00E-03

1.56E-05

4.07E-02

8.50E-02

rs1799853

CYP2C9

cytochrome P450

phase I

C

T

100

0

0

-

-

6.25E-05

-

rs776746

CYP3A5

cytochrome P450

phase I

G

A

81

17

2

2.78E-05

8.74E-05

2.58E-02

1.23E-34

rs10264272

CYP3A5

cytochrome P450

phase I

C

/

100

0

0

1.00E + 00

1.00E + 00

-

8.95E-09

rs6277

DRD2

G-protein-coupled receptor

others

G

A

38

47

15

7.41E-08

1.01E-07

1.98E-02

6.51E-11

rs1800497

DRD2

G-protein-coupled receptor

others

T

C

3.1

29.6

67.4

8.59E-06

1.43E-05

7.19E-01

2.25E-06

rs1695

GSTP1

glutathione S-transferase

phase II

A

G

59

36

5

5.70E-01

1.96E-03

2.32E-04

1.50E-03

rs1138272

GSTP1

glutathione S-transferase

phase II

T

C

0

18

82

3.00E-03

2.00E-03

9.22E-01

2.28E-03

rs3846662

HMGCR

HMGCR

phase I

T

C

18

61

21

2.49E-01

7.26E-01

2.12E-02

2.79E-24

rs3807375

KCNH2

eag

others

A

G

19

48

33

6.73E-07

8.34E-12

4.02E-01

1.13E-11

rs3815459

KCNH2

eag

others

A

G

16

49

35

6.04E-06

2.69E-09

-

6.88E-01

rs1801131

MTHFR

methylenetetrahydrofolate reductase

phase I

C

A

7

56

37

9.07E-03

5.46E-04

2.32E-01

7.36E-09

rs1801133

MTHFR

methylenetetrahydrofolate reductase

phase I

T

C

4

30.3

65.7

3.13E-07

1.21E-03

1.92E-02

9.34E-03

rs3814055

NR1I2

nuclear receptor

others

C

T

30

56

14

8.60E-03

2.15E-03

1.00E-01

1.32E-03

rs701265

P2RY1

G-protein coupled receptor

others

G

A

4

32

64

7.61E-02

3.04E-01

9.33E-01

2.96E-25

rs2046934

P2RY12

G-protein coupled receptor

others

T

C

82

16

2

5.69E-02

4.97E-02

4.49E-03

6.23E-03

rs20417

PTGS2

nuclear receptor

others

G

C

97

0

3

5.43E-04

1.57E-03

3.65E-07

4.82E-17

rs689466

PTGS2

nuclear receptor

others

A

G

73.7

23.2

3

3.68E-11

4.34E-07

7.13E-01

1.12E-01

rs1805124

SCN5A

sodium channel gene

others

G

A

9

40

51

1.23E-04

7.59E-04

7.80E-03

4.96E-01

rs6791924

SCN5A

sodium channel gene

others

G

/

100

0

0

-

-

-

2.00E-03

rs7626962

SCN5A

sodium channel gene

others

G

/

100

0

0

-

-

-

1.24E-03

rs1051266

SLC19A1

solute carrier

others

G

A

29.9

51.6

18.6

3.65E-01

8.28E-02

8.36E-01

2.83E-06

rs4149056

SLCO1B1

solute carrier

others

T

C

82

17

1

2.30E-01

7.68E-01

1.47E-01

2.66E-04

rs4124874

UGT1A10

UDP-glucuronosyltransferase

phase II

C

A

14.4

56.7

28.9

1.64E-02

6.88E-02

3.31E-01

2.73E-23

rs4148323

UGT1A10

UDP-glucuronosyltransferase

phase II

A

G

0

7

93

7.23E-08

3.22E-03

9.00E-02

9.00E-02

rs10929302

UGT1A10

UDP-glucuronosyltransferase

phase II

G

A

53

41

6

2.58E-03

3.31E-03

9.38E-01

4.91E-02

rs1540339

VDR

nuclear receptor

others

G

A

47.5

39.4

13.1

1.60E-10

1.42E-11

7.78E-01

1.80E-02

rs1544410

VDR

nuclear receptor

others

G

A

40

52

8

3.05E-12

2.03E-06

1.75E-02

2.50E-01

rs2239179

VDR

nuclear receptor

others

A

G

31

51

18

4.01E-04

6.14E-05

3.63E-02

8.58E-03

rs2239185

VDR

nuclear receptor

others

T

C

22

58

20

2.86E-04

1.55E-01

-

4.37E-01

rs3782905

VDR

nuclear receptor

others

C

G

46

48

6

1.20E-01

6.72E-04

3.92E-01

7.74E-02

rs7975232

VDR

nuclear receptor

others

C

A

20

58

22

9.30E-05

2.13E-03

1.92E-02

2.44E-02

rs10735810

VDR

nuclear receptor

others

C

T

48.4

36.3

15.4

8.17E-02

8.74E-01

2.72E-01

4.64E-03

rs11568820

VDR

nuclear receptor

others

G

A

60.6

33.3

6.1

1.12E-04

4.25E-05

6.86E-01

8.35E-38

rs7294

VKORC1

VKORC1

phase I

C

T

44

46

10

8.00E-10

1.09E-06

7.69E-01

1.59E-04

rs9934438

VKORC1

VKORC1

phase I

G

A

26

49

25

1.29E-17

4.64E-14

1.01E-01

9.39E-25